What The Study Did: The association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with COVID-19 is investigated in this study.
Authors: Frank L. van de Veerdonk, M.D., Ph.D., of the Radboud University Medical Center in Nijmegen, the Netherlands, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.17708)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Credit:
JAMA Network